Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Increased Bactericidal/Permeability Increasing Protein in Patients With Cirrhosis
Link ID 21964
Title Increased Bactericidal/Permeability Increasing Protein in Patients With Cirrhosis
Url http://www.medscape.com/viewarticle/714991?src=rss
Description What role does increasing plasma levels of bactericidal/permeability increasing protein (BPI) play in patients with cirrhosis? Liver International
Category Articles > Gastroenterology
Keywords
Date Jan 27, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. Lactulose Breath Testing Does Not Discriminate Patients With Irritable Bowel Syndrome From Healthy C
  IV cyclosporine is an effective therapy for patients with IBD; however, data regarding its adverse events in these patients are limited.
The American Journal of Gastroenterology
Category:   Articles > Gastroenterology


2. Rapunzel and Pregnancy
  A 22-year-old Egyptian woman had been suffering from episodes of epigastric pain and vomiting throughout her pregnancy and puerperium.
Southern Medical Journal
Category:   Articles > Gastroenterology


3. Is Appendectomy Effective for Ulcerative Proctitis?
  Ulcerative proctitis can often be managed with appendectomy, Australian investigators reported last week at Digestive Disease Week 2010 in New Orleans. Reuters Health Information
Category:   Articles > Gastroenterology


4. Most Patients With Ulcerative Colitis Remain in Remission After 12 Months of MMX Mesalamine Therapy
  In 2 studies, use of mesalamine with multimatrix system technology for 12 months maintained remission in about two thirds of patients with ulcerative colitis. Medscape Medical News
Category:   Articles > Gastroenterology


5. Irritable Bowel Syndrome: The Possible Benefits of Oral Antibiotic Therapy
  Rifaximin, a minimally absorbed antibiotic, offers promise as a potential treatment of irritable bowel syndrome. AccessMedicine from McGraw-Hill
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS